Schedule 13D ownership disclosure
ImmunityBio Inc
Security class unavailable · CUSIP: 45256X103
Event date: 2023-09-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 39.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-239612
- Form type
- SC 13D
- Filer
- Cambridge Equities, LP
- CIK
- CIK 1629222
- Filed
- Sep 21, 2023
- Reporting period
- Sep 11, 2023
- Description
- Schedule 13D beneficial ownership